文献速递生殖医学

寻求不孕治疗女性中铁摄入与卵巢储备的关系

Iron intake in relation to ovarian reserve among women seeking infertility treatment.
PubMed 文献 · Hum Reprod · 2023-01-01

该观察性研究纳入582名在马萨诸塞州总医院生育中心就诊的女性(2007-2019年),发现补充铁摄入超过45毫克/天与较低卵巢储备相关:与补充铁摄入≤20毫克/天者相比,45-64毫克/天者窦卵泡计数低17%,≥65毫克/天者低32%,且第3天FSH水平升高0.9 IU/ml。

要点

  • 补充铁摄入45-64毫克/天者窦卵泡计数较≤20毫克/天者低17%。
  • 补充铁摄入≥65毫克/天者窦卵泡计数较≤20毫克/天者低32%。
  • 补充铁摄入≥65毫克/天者第3天FSH较≤20毫克/天者高0.9 IU/ml。

核心结论

  • 在寻求生育治疗的女性中,补充铁摄入超过45毫克/天与较低卵巢储备相关。

研究设计与样本

  • 观察性研究,纳入582名在马萨诸塞州总医院生育中心就诊的女性(2007-2019年),为环境与生殖健康(EARTH)研究参与者。
  • 铁摄入通过经验证的食物频率问卷估算;卵巢储备标志物包括经阴道超声评估的窦卵泡计数(AFC)和第3天FSH,均在不孕评估期间获取。

主要发现

  • 参与者中位年龄35岁,中位总铁摄入29毫克/天;总铁摄入与AFC呈负相关,该关联由补充铁摄入驱动。
  • 与补充铁摄入≤20毫克/天者相比,45-64毫克/天者AFC低17%(-35%, 0.3%),≥65毫克/天者AFC低32%(-54%, -11%),校正潜在混杂因素后线性趋势P=0.003。
  • 多变量校正分析中,与补充铁摄入≤20毫克/天者相比,≥65毫克/天者第3天FSH高0.9(0.5, 1.3)IU/ml,线性趋势P=0.02。

临床怎么用

  • 作者认为,鉴于该主题文献匮乏,必须在旨在更好理解该关联在整个卵巢储备分布中的剂量-反应关系以及孕前补铁风险-获益平衡的研究中重新探讨该问题,孕前补铁对妊娠结局有许多积极影响。
  • 作者指出,由于所有研究参与者均寻求生育治疗,其发现可能不适用于一般人群。

局限性

  • 铁摄入通过依赖自我报告的方法估算,参与者无铁状态生物标志物。
  • 仅36名女性补充铁摄入≥45毫克/天。
  • 所有研究参与者均寻求生育治疗,发现可能不适用于一般人群。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

STUDY QUESTION: Is there an association between iron intake and ovarian reserve among women seeking fertility care? SUMMARY ANSWER: Supplemental iron intake above 45 mg/day is associated with lower ovarian reserve among women seeking fertility care. WHAT IS KNOWN ALREADY: Although the literature regarding iron intake in relation to ovarian reserve is scant and inconsistent, some evidence suggests that iron may have gonadotoxic effects. STUDY DESIGN, SIZE, DURATION: This observational study included 582 female participants attending the Massachusetts General Hospital Fertility Center (2007-2019) enrolled in the Environment and Reproductive Health (EARTH) Study. PARTICIPANTS/MATERIALS, SETTING, METHODS: Iron intake was estimated using a validated food frequency questionnaire. Markers of ovarian reserve included antral follicle count (AFC) (assessed via transvaginal ultrasound) and Day 3 FSH, both obtained during the course of an infertility evaluation. MAIN RESULTS AND THE ROLE OF CHANCE: Participants had a median age of 35 years and median total iron intake of 29 mg/day. Total iron intake was inversely related to AFC and this association was driven by intake of supplemental iron. Compared to women with a supplemental iron intake of ≤20 mg/day, women consuming 45-64 mg/day of supplemental iron had a 17% (-35%, 0.3%) lower AFC and women consuming ≥65 mg/day of supplemental iron had a 32% (-54%, -11%) lower AFC after adjusting for potential confounders (P, linear trend = 0.003). Similarly, in a multivariable-adjusted analysis, Day 3 FSH levels were 0.9 (0.5, 1.3) IU/ml higher among women with a supplemental iron intake of ≥65 mg/day when compared to women with a supplemental iron intake of ≤20 mg/day (P, linear trend = 0.02). LIMITATIONS, REASONS FOR CAUTION: Iron intake was estimated using a method that relies on self-report and we had no biomarkers of iron status in our participants; only 36 women consumed ≥45 mg/day of supplemental iron. WIDER IMPLICATIONS OF THE FINDINGS: Since all study participants were seeking fertility treatment, our findings may not apply to women in the general population. Although our findings are consistent with studies of women with iron overload, given the paucity of literature on this topic, it is essential that this question is revisited in studies designed to better understand the dose-response relation of this association across the entire distribution of ovarian reserve and the risk-benefit balance of pre-conceptional iron supplementation given its many positive effects on pregnancy outcomes. STUDY FUNDING/COMPETING INTEREST(S): The project was funded by Grants R01ES022955, R01ES033651, R01ES009718, P30ES000002, and P30DK046200 from the National Institutes of Health. N.J.-C. was supported by a Fulbright Scholarship. N.J.-C., M.M., L.M.-A., E.O.-P., S.W., I.S., and J.E.C. declare no conflict of interest related to the work in the manuscript. R.H. has received grants from the National Institute of Environmental Health Sciences. TRIAL REGISTRATION NUMBER: N/A.

来源:Hum Reprod,查看原文。版权归原作者所有。

引用

  1. Jiménez-Cardozo N, Mitsunami M, Mínguez-Alarcón L, et al. Iron intake in relation to ovarian reserve among women seeking infertility treatment. Hum Reprod. 2023. PMID: 37329261. doi:10.1093/humrep/dead118

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。